Global X Genomics & Biotechnology ETF (GNOM)
NASDAQ: GNOM · Real-Time Price · USD
46.34
+0.14 (0.30%)
Feb 10, 2026, 4:00 PM EST - Market closed
GNOM Holdings Information
GNOM is an equity ETF with a total of 50 individual holdings. The top holdings are Moderna stock at 6.36%, Praxis Precision Medicines at 6.12%, Arrowhead Pharmaceuticals at 5.83%, Guardant Health at 5.46%, and Illumina at 4.62%.
Total Holdings
50
Top 10 Percentage
48.85%
Asset Class
Equity
ETF Category
Health
Assets
50.53M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | MRNA | Moderna, Inc. | 6.36% |
| 2 | PRAX | Praxis Precision Medicines, Inc. | 6.12% |
| 3 | ARWR | Arrowhead Pharmaceuticals, Inc. | 5.83% |
| 4 | GH | Guardant Health, Inc. | 5.46% |
| 5 | ILMN | Illumina, Inc. | 4.62% |
| 6 | VRTX | Vertex Pharmaceuticals Incorporated | 4.23% |
| 7 | BMRN | BioMarin Pharmaceutical Inc. | 4.18% |
| 8 | NTRA | Natera, Inc. | 4.09% |
| 9 | BNTX | BioNTech SE | 4.00% |
| 10 | TECH | Bio-Techne Corporation | 3.96% |
| 11 | RNA | Avidity Biosciences, Inc. | 3.92% |
| 12 | QGEN | Qiagen N.V. | 3.83% |
| 13 | CRSP | CRISPR Therapeutics AG | 2.98% |
| 14 | BMY | Bristol-Myers Squibb Company | 2.67% |
| 15 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.49% |
| 16 | VCYT | Veracyte, Inc. | 2.48% |
| 17 | LLY | Eli Lilly and Company | 2.40% |
| 18 | TWST | Twist Bioscience Corporation | 2.40% |
| 19 | GILD | Gilead Sciences, Inc. | 2.40% |
| 20 | BEAM | Beam Therapeutics Inc. | 2.19% |
| 21 | LON: AZN | AstraZeneca PLC | 2.14% |
| 22 | WGS | GeneDx Holdings Corp. | 2.03% |
| 23 | LEGN | Legend Biotech Corporation | 2.00% |
| 24 | RARE | Ultragenyx Pharmaceutical Inc. | 1.88% |
| 25 | TXG | 10x Genomics, Inc. | 1.80% |
As of Feb 6, 2026